5 December 2018
Release of Restricted Securities
ASX Code: MXC
MGC Pharmaceuticals Ltd (the "Company") confirms that the following restricted securities relating to the Company's original acquisition of the Senegal gold exploration assets in 2012, through the reverse takeover of Erin Resources Limited, have been agreed to be released by the Company from their voluntary holding lock. These shares were part of the original consideration paid to the vendors of Erin Resources. These shares are a legacy issue for the Company, unrelated to the current business and operations of MGC Pharmaceuticals Ltd. They are held by independent third parties and have never been involved in the operations of the Company. | |||
Security Description | Release Date | Number | Applying for Quotation |
Ordinary fully paid shares | 20 December 2018 | 2,316,947 | Already quoted |
following restricted Senegal gold exploration , have been
Erin
ted to the current
independent
--Ends--
1
-
1
Attachments
- Original document
- Permalink
Disclaimer
MGC Pharmaceuticals Ltd. published this content on 05 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 05 December 2018 09:36:15 UTC